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Abstract. Clinical studies of carotenoid macular pigments (M P) have 
been limited by the lack of noninvasive, objective instruments. W e 
introduce a novel noninvasive optical instrument, an M P Raman de­
tector, for assessment of the carotenoid status of the human retina in 
vivo. The instrument uses resonant excitation of carotenoid molecules 
in the visible wavelength range, and quantitatively measures the 
highly specific Raman signals that originate from the single- and 
double-bond stretch vibrations of the ^-conjugated carotenoid mol­
ecule's carbon backbone. The instrument is a robust, compact device 
and suitable for routine measurements of M P concentrations in a clin i­
cal setting. W e characterized and tested the instrument in clinical 
studies of human subjects to validate its function and to begin to 
establish its role as a possible screening test for macular pathologies. 
W e also show that the M P Raman spectroscopy technology has po­
tential as a novel, highly specific method for rapid screening of caro­
tenoid antioxidant levels in large populations at risk for vision loss 
from age-related macular degeneration, the leading cause of blindness 
of the elderly in the developed world. © 2004 Society of Photo-Optical Instru­
mentation Engineers. [DOI: 10.111 7/1.1627776]
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1 Introduction
Age-related macular degeneration (A M D  is the leading cause 
o f blindness in the developed world1 and there is no effective 
treatment for the majority o f patients with this disease. Ac­
cording to recent studies, the macular carotenoid pigments 
MP lutein and zeaxanthin might play a role in the treatment 
and prevention o f AMD.2 These pigments are concentrated in 
the macula lutea, a 5-mm diameter region o f the retina that is 
essential for highest visual acuity and color vision. The 
mechanisms by which these two macular pigments, derived 
exclusively from dietary sources such as green leafy veg­
etables and orange-yellow fruits and vegetables, might protect 
against AMD are still unclear. These pigments are known to 
be excellent free-radical scavenging antioxidants in a tissue at 
high risk o f oxidative damage owing to high levels o f light 
exposure and to abundant highly unsaturated lipids.1,3 In ad­
dition, since these molecules absorb in the blue-green spectral 
range, they act as filters that may attenuate photochemical 
damage caused by short-wavelength visible light reaching the 
retina.4
There is considerable interest in the noninvasive measure­
ment o f macular carotenoid levels in the elderly population to 
determine whether low levels o f macular pigment are associ­
ated with increased risk o f AMD.5 Currently the most com­
monly used noninvasive method for measuring human macu­
lar pigment levels is a subjective psychophysical 
heterochromatic flicker photometry test involving color inten­
sity matching o f flickering blue and green light aimed at the 
fovea with the same light aimed at the perifoveal area.6 This 
method is time intensive and requires an alert, cooperative
subject with good visual acuity, and there may be high intra­
subject variability when macular pigment densities are low or 
if significant macular pathology is present.7 Thus the useful­
ness o f this method for assessing macular pigment levels in 
the elderly population most at risk for AMD is severely lim­
ited. Nevertheless, researchers have used flicker photometry 
to investigate important questions such as variation o f macu­
lar pigment density with age and diet. In a recent flicker pho­
tometry study, for example, the pigment density was found to 
increase slightly with age,8 but another study found the oppo­
site trend.5 Several objective techniques for the measurement 
o f macular pigment in the human retina have been explored 
recently as alternatives to the subjective psychophysical tests. 
The underlying optics principles o f these techniques are based 
on either fundus-reflection9,10 or fundus-fluorescence (autof­
luorescence spectroscopy;11 however, all o f them suffer from 
numerous assumptions and limitations.12
Recently we demonstrated a novel optical approach to in 
vivo detection o f MP13,14 based on resonance Raman scatter­
ing. The technique is objective as well as noninvasive and 
appears to be fast and quantitative; its exquisite specificity 
means that it could be used for patients with a variety of 
ocular pathologies. In this paper we describe the underlying 
principles of the MP Raman technology and the instrument 
used for clinical MP measurements. We characterize the in­
strument, discuss the physical meanings o f the data obtained, 
and discuss various potentially confounding measurement 
conditions. We show that the Raman technique holds promise
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Fig. 1 (a) Chemical structure of lutein and zeaxanthin molecules. 
They differ in the location of the additional C = C  bond in one ionone 
ring. (b) Energy-level diagram of long-chain carotenoid molecules 
with optical and nonradiative transitions.
for a major advance in the study and possibly the early diag­
nosis o f macular degenerative diseases. Besides the retina, the 
technology can also be used as a potential early diagnostic test 
o f disorders in human skin and the oral cavity.15,16
Fig. 2 Absorption spectra of excised, flat-mounted human retina 
(curve a), lutein (curve b), and zeaxanthin (curve c) dissolved in 
methanol. Note the remarkable similarity of the retinal tissue absorp­
tion to the absorption of carotenoid solutions.
2 Optical Properties of Carotenoids
Lutein and zeaxanthin carotenoid molecules Fig. 1 a are 
similar to polyenes in their structure and optical properties. 
Their carbon backbones contain nine alternating conjugated 
carbon double C C and single C C, bonds. The carbon 
backbone is terminated at each end by an ionone ring to 
which a hydroxyl group is attached. Four methyl groups are 
attached to the backbone as side groups. Zeaxanthin differs 
from lutein only in the location o f one o f the double bonds 
and in the stereochemistry o f the 3' carbon site.
An energy-level diagram o f the carotenoid molecule is 
shown in Fig. 1 b . We use labels associated with the irreduc­
ible representations belonging to the C2h point group to de­
scribe the symmetries o f the electronic states o f carotenoids. 
Human retinal tissue contains high concentrations o f lutein 
and zeaxanthin. The absorption o f these molecules and the 
monotonically decreasing scattering background account for 
the complete absorption behavior o f the macula, as seen in 
Fig. 2. The strong electronic absorption occurs in a broad 
band (about an 80-nm width centered at about 450-nm, and 
shows a clearly resolved vibronic substructure with a spacing 
o f 1400 cm -1. The absorption is caused by electric dipole- 
allowed vibronic transitions o f the molecule's conjugated 
7r-electron from the 11A g singlet ground state to the 11Bu 
singlet excited state see Fig. 1 b . Optical excitation within 
the absorption band leads to weak luminescence not shown, 
peak at 530-nm, width 50-nm) with a small Stokes shift, 
which again shows vibronic substructure.
By analogy with that o f the well-studied -carotene mol­
ecule, the extremely low quantum efficiency o f the lutein- 
zeaxanthin luminescence is caused by the existence o f a sec­
ond excited singlet state, a 2 1 A g state, which lies below the 
11Bu state. Following optical excitation o f the 11Bu state, the 
energy relaxes rapidly (within approximately 200-250 fs in 
/3-carotene17) by nonradiative transitions to the lower 2 1A g 
state, from which electronic emission to the ground state is
symmetry forbidden. The extremely low luminescence 1 1Bu 
^ 1 1A g and the absence o f 2 1 Ag-^ > 11 A g fluorescence of 
lutein-zeaxanthin allow us to measure the resonant Raman 
scattering response o f the molecules without potentially inter­
fering intrinsic fluorescence signals.
The Raman spectrum o f carotenoid molecules, shown in 
Fig. 3, is characterized by two prominent Stokes lines at 1159 
and 1524 cm-1, originating, respectively, from the C— C 
single-bond and the C C double-bond stretch vibrations of 
the conjugated backbone. A  weaker peak at 1008 cm -1 is 
attributed to the rocking motion o f the molecule’s methyl side 
groups.18 As is evident from Fig. 3, both lutein and zeaxanthin 
have very similar resonance Raman spectra in terms o f Ra­
man shifts and peak widths at room temperature. The Raman 
signals are superimposed on a weak fluorescence background 
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Fig. 3 Resonant Raman spectrum of methanol solution of zeaxanthin 
and lutein measured under excitation with a 488-nm argon laser line. 
The horizontal dashed line indicates zero for the Raman spectrum of 
zeaxanthin, which was shifted by 900 counts for the sake of clarity.
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Fig. 4 The setup of the fiber-based M P Raman detector, an instrument 
for quantitative measurements of macular carotenoid pigment content 
in clinical settings.
cence that varies slightly in spectral shape and strength, de­
pending on the type o f carotenoid molecule. In all cases the 
intensity ratio between Raman signal and background fluores­
cence is about 0.8:1 at the spectral position o f the C = C  Ra­
man peak. We also found that Raman signal intensity is pro­
portional to the concentration o f the molecules in optically 
thin solvents, as is expected for a linear spectroscopic tech­
nique like Raman spectroscopy. Therefore the Raman peak 
height can be used as a measure o f the carotenoid content of 
optically thin samples.
3 Raman Detector and Computer Interface
Initially we used Raman spectroscopy to measure flat- 
mounted human retinas and excised eye cups.19 For the mea­
surement o f living human eyes, the ocular light exposure dur­
ing a measurement must be limited to prevent both 
photochemically and thermally induced retinal injury, as 
specified by the safety regulations o f the American National 
Standards Institute. Furthermore, for an instrument to be use­
ful in a clinical setting, it needs to be highly specific, sensi­
tive, and robust. To meet all these requirements, we developed 
a compact, portable, fiber-based, and computer-interfaced Ra­
man instrument. The layout o f this MP Raman detector is 
shown schematically in Fig. 4. The instrument sacrifices un­
needed spectral resolution for the benefit o f increased light 
throughput. Also, it can be interfaced to a fundus camera to 
help monitor the delivery o f the excitation laser beam to the 
foveal area o f the retina in living eyes. The instrument con­
sists o f a beam delivery and collection optics module mounted 
on a kinematic positioning system, a small argon laser, a Ra­
man spectrograph coupled with a thermoelectric cooled CCD 
camera, controlling electronics, and a computer interface.
The beam delivery and collection optics module is shown 
in the lower left part o f Fig. 4. The excitation laser beam 
originates from a small air-cooled argon laser operating on the 
488-nm line. It is routed via an optical fiber into the module, 
collimated by lens L2, transmitted through filter F, and re­
flected by mirror M ; it then passes through a dichroic beam­
splitter BS, and is finally imaged onto the macula by a com­
bination o f an auxiliary lens L3, and an eyepiece. The laser-
excitation fiber is a multimode fiber with a core diameter of 
550 /xm and a numerical aperture NA=0.22. The dielectric 
bandpass filter F, which is placed in the excitation path, 
blocks any spectral components outside a narrow 3-nm band­
width centered around the 488-nm excitation wavelength. 
This blocking effectively suppresses fiber fluorescence and 
laser plasma lines in the Raman-scattering spectral range of 
interest. The Raman-scattered, wavelength-shifted light is col­
lected in 180-deg backscattering geometry with the same 
eyepiece-lens combination used to deliver the excitation beam 
and is reflected by the dichroic beamsplitter into a separate 
light collection path. A holographic rejection notch filter NF, 
which effectively blocks the Rayleigh light components of the 
scattered light occurring at the excitation wavelength, is 
placed in this path prior to coupling the Raman-scattered light 
with a collection fiber using lens L4. The holographic rejec­
tion notch filter NF suppresses the excitation light by six or­
ders o f magnitude while transmitting the Raman-shifted light 
components with 80% efficiency. The light collection fiber is 
a fiber bundle consisting o f 96 individual multimode fibers, 
each with a 70- m core diameter, and higher than 55% over­
all transmission owing to a high fiber filling factor. The input 
cross-section o f the fiber bundle is circular (1-mm diameter) 
and the output cross-section is rectangular 70 m 8.6 mm 
to match the rectangular input slit geometry o f a homemade 
spectrograph designed for high light throughput.
The spectrograph employs two achromatic lenses for light 
collimation and a volume holographic transmission grating 
(VHTG). The line density o f the VHTG is 1200 m m 1, and 
the diffraction efficiency is higher than 80% for nonpolarized 
light. The /-number o f the spectrograph is 2 and thus is ideally 
matched to the /-number o f the individual multimode fibers 
comprising the fiber bundle.
The dispersed spectrum is imaged onto the 8.63X6.53-mm 
silicon chip Texas Instruments, model TC-241 o f a CCD 
camera Santa Barbara, Inc., model ST6v . The CCD chip 
consists o f an array o f 750X121 pixels, each having an area
11.5X27 ^m. It has a relatively low detector noise, with a 
combined dark and readout noise smaller than about 8 counts. 
The quantum efficiency o f this chip in the blue-green spectral 
range o f interest is about 55%. We chose to vertically bin 
pixels oriented perpendicular to the dispersion plane o f the 
spectrograph into ‘ ‘ super pixels’ ’ and thus achieved simulta­
neously a low readout noise 24 counts per super pixel and a 
high readout speed (0.5 s per spectrum. The resolution limit 
o f our Raman spectrograph is about 20 cm 1.
The MP Raman detector has several provisions to aid in 
the optical alignment o f the instrument for the human eye. An 
optical shutter is designed so that even in the closed state a 
very small portion o f the blue argon laser light used for Ra­
man excitation is transmitted. A subject looking into the in­
strument thus sees a blue spot originating from the end face of 
the excitation light delivery fiber. Using a proper choice of 
focal lengths for lenses L2, L3, and the eyepiece, we realized 
a 1:2 magnification, effectively imaging the excitation fiber 
end face into a 1-mm diameter spot on the retina. Further­
more, using a low-power light-emitting diode (L E D , we gen­
erated an additional red polka-dot pattern, originating from 
the facets o f the light collection fiber bundle as an alignment 
aid for the subject. With the focal length o f lens L4 chosen to 
be twice that o f lens L2, the 1-mm circular face o f the red
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Fig. 5 Measuring M P level. The subject looks into the instrument and 
adjusts the optical alignment while resting the forehead against the 
device.
illuminated fiber bundle is imaged at the patient’s retina as a 
1-mm spot and thus has a slightly smaller diameter than the 
blue illuminated retinal excitation spot.
The use o f the MP Raman detector is illustrated in Fig. 5. 
Prior to a measurement, the subject overlaps the blue disk and 
the red polka-dot pattern, as shown in Fig. 6, to ensure proper 
alignment o f his or her eye with respect to the instrument. 
This alignment is achieved by suitable positioning o f the 
head. The subject can wear his or her usual glasses or contact 
lenses if needed (see later discussion regarding their influence 
on the Raman response . After the subject has signaled align­
ment, the instrument operator pushes a trigger button. The 
synchronized electronics momentarily turns off the red LED 
aiming beam to avoid exposure o f the CCD detector, opens 
the shutter to allow laser light to project onto the retina, and 
triggers the data acquisition system. After a preset measure­
ment time of 0.25 s, the instrument closes the laser shutter, 
digitizes the backscattered light, downloads the data into com­
puter memory, and initiates software processing for spectral 
display.
Fig. 6 Procedure for alignment of the Raman instrument with the op­
tical axis of the subject's eye. The subject sees two colored light pat­
terns when looking into the instrument: a weak blue circular disk from 
the argon laser fiber (shown in gray) and a weak red polka-dot pattern 
originating from an LED-illuminated light-collection fiber bundle. 
Alignment is achieved when the subject moves his or her head so that 
both patterns overlap. (a) Misaligned;(b) aligned.
The instrument is interfaced to a small personal computer 
with home-developed Windows-based software for data ac­
quisition and processing. All post-exposure processing takes 
only 0.25 s, and thus the instrument provides an almost in­
stantaneous display o f the final Raman spectrum and other 
operating parameters on the computer monitor after each mea­
surement. Using the Windows-based computer interface, the 
software facilitates a number o f other functions. It permits the 
operator to properly initiate the hardware, and it establishes 
all necessary communication between the computer and the 
CCD camera. It automatically measures the dark spectrum 
and subtracts it whenever a ‘ ‘ light’ ’ measurement is made; 
processes the spectra; saves the data as text ASCII files; and 
finally prompts the operator to properly shut down the instru­
ment.
4 Safety Considerations
To comply with ANSI safety regulations, the ocular exposure 
levels used in our Raman instrument have to stay below cer­
tain specified threshold levels. According to the latest issue, 
ANSI Z136.1-2000,20 ocular exposure levels have to be lim­
ited to protect the eye from both photochemically and ther­
mally induced retinal injury under measurement conditions 
(visible light near 0.5 fim, immobilized eyes, exposure time 
o f 0.25 s). The photochemical limit for retinal injury (Sec. 
8.3.1 o f the ANSI guidelines) is listed as 2.7 CB J/cm2, where 
CB is a wavelength correction factor, and results in 15.5 J/cm2 
with CB =  5.75 for 488-nm. The thermal limit for retinal in­
jury (Sec. 8.3.2), valid for an exposure time o f 0.07< t 
0.7 s, has to be calculated from the laser spot present at the 
cornea and is listed as 1 .8 (a /1 .5 )1075 mJ/cm2. Here a is the 
angle o f the laser source at the location o f the viewer, mea­
sured in milliradians. Using t =  0.07 s and a  =  58.8 
X 10-3 rad, we obtain an energy density o f 9.6 mJ/cm2 at the 
cornea for the thermal exposure limit o f the retina.
In a typical single-exposure measurement with our instru­
ment (0.25-s ocular exposure with 1 mW light at 488-nm , a 
total laser energy o f 0.25 mJ is projected onto an 8-mm- 
diameter spot at the cornea and a 1-mm-diameter spot on the 
retina. This corresponds to a retinal exposure level o f 32 
mJ/cm2, which is 480 times lower than the 15.5 J/cm2 photo­
chemical limit. For the ocular exposure used, we calculate a 
level o f 0.5 mJ/cm2 considering that the light energy o f 0.25 
mJ is distributed over a spot with an 8-mm diameter at the 
cornea; therefore this exposure level is 19 times lower than 
the thermal limit o f 9.6 mJ/cm2 for retinal injury.
5 Raman Measurements
The appearance o f the computer monitor after a typical mea­
surement is shown in Fig. 7. On the left side o f the screen a 
safety and dosimetry control table is displayed. This table 
shows the exposure dose as a function o f the excitation laser 
power and exposure time chosen, and the area o f the excita­
tion spot on the retina. It also contains the ratio o f the light 
dose with respect to the maximum permissible exposure dose. 
As can be seen from the table, under typical experimental 
conditions (exposure time 0.25 s, laser power 1 mW, spot size 
1 m m , a safety factor o f 19 is obtained.
The central part o f the screen shows the measured Raman 
spectrum superimposed on a spectrally broad background
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Fig. 7 Display of a typical Raman measurement of human M P on the computer monitor. See text for details.
spectrum caused by fluorescence o f the retina. This spectrum 
is a difference spectrum resulting from the subtraction o f a 
dark spectrum recorded before a measurement from the 
measured spectrum. The observer may view this spectrum to 
obtain general spectral information, i.e., the shape and height 
o f the combined fluorescence-Raman spectra.
The right part o f the screen displays the measured caro- 
tenoid Raman spectrum after subtraction o f the overlapping 
fluorescence background, which is accomplished by polyno­
mial fitting o f the background spectrum and subsequent sub­
traction from the spectrum displayed in the central window. 
To derive the shape o f the background, we use all data points 
in the selected wavelength range except those in the vicinity 
o f the Raman peaks. All these data points are curve fitted to a 
user-selected polynomial o f up to the fourth order, and the 
computed polynomial curve is subtracted from the original 
spectrum. This results in a curve containing spectral informa­
tion exclusively from the Raman response o f the macular 
carotenoids. We found that the shapes o f the lutein and zeax- 
anthin spectra were not distinguishable from the shape o f hu­
man MP Raman spectra.
To obtain an accurate reading o f the Raman peak heights, 
we eliminated the influence o f potentially overlapping noise 
spikes in the spectrum by fitting the measured Raman line 
shapes with Lorentzians in a single-parameter fit, where we 
used the known wavelength positions and instrumentation- 
broadened spectral widths o f the Raman peaks o f interest. 
The calculated values for the intensities o f the C C single­
bond and C C double-bond peaks, along with the values for 
the fluorescence intensity under those peaks, and the ratios of 
the Raman intensities to the background, are tabulated in a 
report window see the lower middle part o f Fig. 7 . The final 
peak height o f the C==C double bond signal at 1524 cm^1 is
chosen as a measure o f carotenoid concentration. To aid in 
clinical studies, this window allows one to enter the subject’s 
personal data; it contains a dated time stamp and it saves this 
information along with the spectra.
If needed, it is possible to improve the quality o f the spec­
trum, i.e., the signal-to-noise ratio, by summing over up to 
four neighboring pixels in a binning-mode option lower right 
part o f Fig. 7 . Furthermore, markers indicating the signal 
strength for Raman peaks and the baseline can be used to 
evaluate the quality o f the data processing.
The spectral details o f an MP measurement obtained with 
the instrument are summarized in Fig. 8 and Table 1. Spec­
trum a in Fig. 8 was obtained from a human macula and 
spectrum c is the amplitude-adjusted spectrum from zeaxan- 
thin dissolved in ethanol. Spectrum b in Fig. 8 represents the 
difference between macular and authentic zeaxanthin spectra 
and therefore has to be assigned to the fluorescence spectrum 
o f an ‘ ‘unpigmented’ ’ retina. According to the literature,21 this 
fluorescence is most likely due to lipofuscin, a major retinal 
fluorophore located in the retinal pigmented epithelium RPE 
cells, whose function in the eye has not as yet been defined. 
According to the retinal spectrum decomposition, only 21% 
o f the signal intensity is contributed by the MP Raman signal; 
the remaining fractions, 27 and 52%, originate from caro­
tenoid and lipofuscin fluorescence, respectively. Obviously, 
the ratio o f the carotenoid Raman signal to carotenoid fluo­
rescence under a fixed-excitation wavelength will remain the 
same in any macula. However, the fraction o f lipofuscin fluo­
rescence in the macular spectrum might vary from person to 
person, depending on several factors, such as MP content and 
age. The age factor is essential since the human retina sup­
posedly accumulates lipofuscin with increasing age.21
Journal of Biomedical Optics • January/February 2004 • Vol. 9 No. 1 143
Ermakov et al.
Fig. 8 Spectral decomposition of a typical macular spectrum, (curve 
a) indicating the contributions of retinal autofluorescence (curve b) 
and a carotenoid Raman spectrum (curve c).
Fig 9 Measured variation in the Raman signal with pupil diameter for 
a human subject (circles). The dashed curve is the theoretically ex­
pected change in the signal with pupil diameter. Above a 7-mm pupil 
diameter, the signal stays constant (see text).
6 Pupil Diameter and Raman Intensity
It is useful to show how the pupil diameter would affect the 
Raman signals measured with the instrument. The dependence 
o f the Raman response on pupil diameter d can be understood 
by considering the geometric light throughput o f the instru­
ment, F inst, which is designed with an effective aperture o f 7 
mm defined by the magnified aperture o f the light-collection 
fiber bundle), and the light throughput o f the eye, F eye, which 
scales quadratically with pupil diameter. Both result in the 
overall throughput o f the system (eye plus MP detector): 
F syst=  min{Finst,F eyJ , which is indicated in Fig. 9. The in­
strument aperture limits the overall light throughput to Fsyst 
F inst for d 7 mm. The light throughput o f the eye is given 
by F eye=  kd1, where k is a constant accounting for the trans­
mission properties o f the average human eye. The total light 
throughput o f the system is thus controlled by the pupil diam­
eter for the case d 7 mm, and it is limited by F instr when d 
exceeds a 7-mm diameter.
In one set o f measurements, the subject was measured re­
peatedly while his pupil was dilated pharmacologically. Be­
tween measurements the pupil’s diameter was measured in 
ambient light. As shown in Fig. 9, the carotenoid Raman 
C C peak intensity circles gradually increases as the pupil 
slowly dilates to its maximum diameter, leveling off at about
T ab le  1 Signal components of a typical M P Raman measurement.
Signal Intensity Percentage
Retina fluorescence (lipofuscin) 4 604 52%
Carotenoid fluorescence 2361 27%
Carotenoid Raman signal 1889 21%
Overall signal 8854 100%
7 mm. In the fully dilated state, for some individuals the sig­
nals can be twice as large as in the undilated state.
The data in Fig. 9 reveal that measured signal levels are 
noticeably higher than the levels for pupil diameters below 6 
mm. This effect appears because the incompletely dilated pu­
pil is still changing its diameter while it is being measured. 
When initially exposed to the bright excitation beam, the eye 
reflex contracts the pupil from a dark-adapted large diameter 
to a smaller diameter determined by the counteracting effects 
o f light intensity and progressing pharmacological immobili­
zation. Since light exposure and pupil reaction time are com­
parable (—0.25 s), the effective pupil diameter is higher than 
the diameter measured under ambient light conditions which 
is shown as the abscissa in Fig. 9 . As a consequence of these 
pupil diameter effects, for clinical instrumentation trials we 
chose to measure only fully dilated pupil diameter 7 to 8 
mm , immobilized eyes o f subjects, thus ensuring maximized 
light throughput as well as consistent measuring conditions 
under bright-light exposure.
7 Instrument Calibration
To find a correlation between the Raman readings and the 
actual carotenoid content o f the living macula, we conducted 
calibration experiments using thin, 1-mm path length quartz 
cuvettes filled with carotenoid solutions and placed them in a 
focal plane o f a positive lens with a focal length o f 22 mm. 
Such a lens is known to approximate the refractive properties 
o f a human eye. The effective excitation volume then is a 
cylinder with a length o f 1.0 mm and a base diameter o f 1.1 
mm the diameter o f a laser beam , resulting in a sampling 
volume o f about 1 l. As calibration materials we initially 
chose freshly prepared ethanol solutions o f zeaxanthin and 
lutein with varying but known carotenoid content in the 1- l 
sampling volume and corresponding to the average carotenoid 
concentrations typically found in excised human macular 
samples as measured by high pressure liquid chromatogra­
phy . Also, we measured the absorption o f these samples with 
a precison UV/visible spectrometer.
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Fig. 1 °  Calibration curve of the M P Raman detector linking the instru­
ment reading with the carotenoid content in a human macula. The 
curve was obtained using a model eye discussed in the text containing 
zeaxanthin dissolved in methanol. The sampling volume, 1 /xl, corre­
sponds to a 1-mm-diameter spot at a macula and contains carotenoid 










" « * » « « .  • ** • • •






RSD= 1.1% RSD = 5.3% RSD = 5.1%
Fig. 11 Repeatability of Raman measurements. The left part represents 
data for zeaxanthin solution in a model eye. The central and right data 
represent the short-term and long-term repeatability of macular pig­
ment measurements for two different subjects. The Raman intensities 
for the long-term dataset were measured over a 2-week period in five 
sessions.
correction can be integrated into the instrumentation software. 
In particular, this means that the theoretically expected shape 
o f the calibration curve
Using the MP Raman detector described, the model eye, 
and the solutions, we obtained the calibration results shown in 
Fig. 10 for zeaxanthin which is the predominant carotenoid 
in the central part o f the human fovea . The concentration axis 
shown at the top o f Fig. 10 indicates the carotenoid concen­
tration calculated for the sampling volume using the published 
extinction coefficient for zeaxanthin.22 The calibration curve 
for lutein not shown essentially coincides with that for ze- 
axanthin since both the Raman excitation efficiency and the 
extinction coefficient are virtually equal for both carotenoids. 
The calibration response directly correlates the Raman re­
sponse (i.e., the C = C  peak height) with the concentration of 
carotenoids and also shows that linear tracking o f carotenoid 
concentrations is possible for low and moderate concentra­
tions, as is the case for the living human macula.
A deviation from the linear response occurs, however, as 
expected, at higher MP densities, i.e., at MP densities in ex­
cess o f an optical density >0.25 (measured at 450 n m  where 
self-absorption o f the Raman-shifted light occurs. The mea­
sured calibration curve is not only useful for correcting MP 
Raman signals at higher concentrations, but also serves as a 
direct correlation between the Raman signal and average MP 
carotenoid content measured in nanograms per milliliter or 
correlated with the optical absorption coefficient and optical 
density.
It is important to note that MP optical density values for 
Raman spectroscopy and heterochromatic flicker photometry 
are not readily comparable. This is because the Raman 
method measures the carotenoid content averaged over the 
entire region illuminated by the 1-mm spot, whereas psycho­
physics measures the optical density only at the edge o f the 
illumination spot.6 Recent studies comparing the two tech­
niques in the same subjects do confirm a significant correla­
tion between them, however.
The calibration curve does not usually change during the 
lifetime o f a particular Raman instrument and hence the data
( 1 - e ^ kD)
will remain the same for any given MP detector using a wave­
length o f 488-nm for the MP Raman signal excitation, but the 
amplitude o f the curve, A, must be found for each instrument 
by performing the calibration procedure described earlier in 
order to ensure a cross-calibration between individual instru­
ments.
8 Sources of Noise and Errors in MP 
Measurements
For daily sensitivity calibration purposes, instead o f the de- 
gradable liquid carotenoid solutions, we developed a chemi­
cally and photostable solid-state alternative that is Raman ac­
tive in the same spectral region as the carotenoid C C and 
C = C  stretch vibrations. This material is a thin slab o f pol­
ished diamond, combined with a positive lens ( / =  22 mm ), 
and housed in a small, 30 35-mm cylinder attachable to the 
front end o f the Raman instrument. The Raman intensity of 
the diamond material has the same order o f magnitude as an 
average Raman signal from the human retina and its short­
term day-to-day and long-term month-to-month stability 
was tested to be tighter than 1%. We obtained comparable 
accuracies also for zeaxanthin and lutein solutions in the 
model eye; i.e., relative standard deviations (RSDs) for five 
measurements were as low as 1.1% (see Fig. 11).
Regarding the noise and error analysis o f the instrument, 
we list in Table 1 and Table 2 the Raman signal strengths 
obtained from the macula o f a young human subject, along 
with the noise levels o f the signals. Also, we list in Table 2 the 
expected noise components associated with photon and detec­
tor noise. The data allow one to conclude that the measure­
ments are ‘ ‘photon limited’ ’ since the photon noise, Nph , ex­
ceeds the detector noise, ND . Thus the main source o f noise 
is the quantum mechanically limited photon noise or shot 
noise, which is unavoidable and is a part o f a measurement. 
The signal contributions, listed in Table 1, indicate that the
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Table 2  Sources of noise in the MP Raman detector.
Parameters Value
CCD  quantum efficiency V 0.54
CCD  analog to digital conversion gain, e 9 3.35
Measured signal intensity, count r/X 1/g 8854
Predicted photon noise, count 1 _ ___
Nph = - \ VXl
51
Measured detector noise, count Nd 33
Predicted overall noise, count 'jNl-l r;'Xl/g2 61
Measured overall noise, count N s 65
Signal-to-noise ratio for C = C  peak, viI-Ibg) 1 889/65:
gNv
Main source of noise Photon noise
intensity o f the useful carotenoid Raman signals is only 21% 
o f the overall intensity o f the measured spectrum. Therefore 
the main contribution to the photon noise comes from the 
fluorescence excited along with the carotenoid Raman signal. 
In spite o f this disadvantage, the signal-to-noise ratio for the 
Raman response in a typical single experiment is very high 
about 10 to 20 , and can exceed a factor o f 30 for subjects 
with high MP content.
To evaluate short-term repeatability in human MP mea­
surements, we measured the MP in the same pupil-dilated eye 
six times with 3 to 4-min intervals between measurements. 
These time intervals ensured that afterimages from the laser 
exposure had faded. The results are shown in Fig. 11. The 
relative standard deviation was 5.3% for this dataset and thus 
about five times higher than the RSD for the ideal carotenoid 
sample (1 .1% . Next, we repeated the MP measurements in 
five consecutive sessions for another subject over a 2-week 
period using pupil dilation for each set o f measurements. In 
this case, the standard deviation was 5.1%. These results 
clearly demonstrate the high accuracy o f the Raman instru­
ment and prove that the RSDs in humans are always higher 
than the RSDs o f carotenoid samples. This increased RSD 
effect obviously is due to the human factor, i.e., the measure­
ment conditions deviate from the perfect optical alignment 
conditions. Each measurement o f a human subject is affected 
by eye alignment errors, and the average value o f these errors 
varies from person to person involved in the study, depending 
on factors such as visual acuity, fixation ability, and alignment 
experience. We observed a wide range o f alignment errors, 
varying from 3 to 15%. Interfacing the Raman detector with a 
standard fundus camera could significantly reduce the align­
ment error since it would allow the operator to monitor the 
alignment quality so that measurements are initiates only 
when the eye is properly aligned. Another, practically quite 
useful alternative, is to accept datasets obtained from an indi­
vidual MP measurement session only if the RSD stays within 
a reasonably low range.
9 Influence of Contact Lenses and Eyeglasses
Since a significant number o f subjects might use correcting 
eyeglasses during measurements, we analyzed whether this 
would influence the MP results. We considered two major 
effects associated with thin lenses having no intrinsic absorp­
tion in the visible spectral range. One deals with Fresnel 
losses at the refracting surfaces. The reflected light from a 




where n is the refractive index o f the lens. For uncoated 
lenses, the single-pass losses, [R +  R (1 — R) ] ^ 2 R , will be as 
high as 8% for CR 39 plastics (n =  1.498), and 9.6 to 10.7% 
for the most commonly used high-index lenses with refrac­
tive indices o f 1.56 and 1.60). As a consequence, the Raman 
excitation will be reduced by 8 to 11% Fresnel losses, and the 
overall MP Raman response by about 16 to 22%. This situa­
tion is the worst-case scenario for uncoated eyeglasses. Cur­
rently, the eyeglass industry offers a wide variety o f corrective 
eye wear, including lenses with antireflection AR coatings, 
scratch-resistant coatings, and photochromic lenses whose 
transmission varies with light intensity. This needs to be taken 
into account since the losses o f AR-coated lenses could be as 
low as a few percent and could be neglected in most cases, 
while photochromic eyeglasses could attenuate the Raman 
signals by an order o f magnitude. Unlike eyeglasses, contact 
lenses normally do not introduce any sizable effect because of 
the almost perfect index matching at the cornea-lens interface 
and owing to the comparable losses existing at the cornea-air 
and contact lens-air interfaces.
A  second major influence on the Raman readings is caused 
by the fact that correction lenses change the size o f the retinal 
images relative to the image size o f the normal eye magnifi­
cation for positive power lenses and image reduction for
2n
n
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Fig. 12 Relative variation in the laser light intensity at the retina with 
the optical power of correcting spectacles or contact lenses. These 
curves should be used on a regular basis for adequate correction of 
M P Raman data when the subject has used his or her lenses during 
M P measurements.
negative power lenses). The magnitude o f this effect depends 
on the respective lens power and its vertex distance he , speci­
fied as the distance from the correction lens to the eye’s en­
trance pupil and not to the cornea . Assuming that the lens is 
typically placed 15-mm in front o f the cornea and that the 
entrance pupil’s location is 3.05-mm inside the eye,24 the 
value o f the vertex distance will amount to he=  15 +  3.05 
=  18.05 mm. Contact lenses can be treated in a similar man­
ner, with a resulting vertex distance o f about 3.05 mm (he 
^  0 +  3.05 =  3.05 mm ). This nonvanishing vertex distance 
means that even contact lenses have a magnification effect, 
although it is much smaller than a corresponding eyeglass 
lens.
Using a ray-tracing program, we calculated the correction 
factors to be used for MP data obtained from subjects wearing 
myopic or hyperopic correction lenses. For myopic correction 
there is a reduction in image size, and for hyperopic correc­
tion there is an increase in image size compared with the 
normal eye. The measured Raman signal scales with the sec­
ond power o f the diameter o f the retinal excitation spot since 
the Raman intensity is a linear function o f power density. The 
resulting plot for the correction factor as a function o f a cor­
rection lens power is shown in Fig. 12.
In Table 3, we summarize all the influences o f optical cor­
rection devices discussed here that a subject might wear dur-
Tab le  3  Effects of optical correction on Raman signal.
Correction Type
Effects Spectacle Lens Contact Lens
Intrinsic losses No No
Fresnel losses Up to 22% reduction 
in Raman signal
No
Magnification Significant increase or 
reduction in Raman signal
Virtually small 
effect
ing MP measurements. In order to make the necessary correc­
tions to the measured Raman data, the instrument operator 
simply looks up the type and characteristics o f the correction 
optics and determines the product o f correction factors using 
Fig. 12. It is clear from Table 3 that contact lenses are pre­
ferred over eyeglasses and that the instrument operator should 
encourage subjects to use contact lenses whenever possible. 
Indeed, as seen from Fig. 12, for moderate optical power of 
contact lenses (diopter ranging from —8 to +8) the correction 
factor for the Raman signal is less than several percent.
10 First Clinical Results and Conclusion
The experiments described here, along with the recent valida­
tion trials we performed in our laboratories,14,25 demonstrate 
that the MP Raman instrument is suitable for clinical environ­
ments. The test is easily performed by human subjects, even 
in the presence o f significant macular pathologies. Measure­
ment repeatability is high as long as the subjects have central 
fixation with a visual acuity o f 20/80 or better. The test is 
rapid (0.25 s), and light exposure levels for the macula are 
well within established laser safety standards. Excitation light 
intensities are sufficiently high, however, to generate afterim­
ages. This necessitates about a 2-min wait between exposures.
First clinical studies25 carried out at the University of 
Utah’s Moran Eye Center revealed that carotenoid Raman sig­
nal intensities declined with age in normal eyes. This decline 
is too strong to be entirely explainable as a decrease in ocular 
transmission with age.12 A corroborating observation is the 
fact that younger subjects o f similar ages and comparable 
lens opacities had drastically varying MP levels. These find­
ings increase the potential usefulness o f the MP Raman detec­
tion technology in screening young subjects for their levels of 
future AMD risk. Our studies also showed that average levels 
o f lutein and zeaxanthin were 32% lower in AMD eyes com­
pared with normal elderly control eyes as long as the subjects 
were not consuming high-dose lutein supplements. Patients 
who had begun to consume supplements containing high 
doses o f lutein 4 mg/day regularly after their initial diag­
nosis o f AMD had average MP levels that were in the normal 
range and that were significantly higher than in AMD patients 
not consuming these supplements.25
These findings are consistent with the hypothesis that low 
levels o f MP in the human macula may represent a pathogenic 
risk factor for the development o f AMD. Resonance Raman 
measurement o f macular carotenoid pigments could play an 
important role in facilitating large-scale prospective clinical 
studies o f lutein and zeaxanthin protection against AMD, and 
this technology may someday prove useful in the early detec­
tion o f individuals at risk for visual loss from AMD.
In conclusion, we find that resonance Raman spectroscopy 
is a highly promising technology for the clinical measurement 
o f macular carotenoid levels in living human subjects. It is 
noninvasive, precise, sensitive, specific, rapid, reproducible, 
and objective. Currently, the technology has been transferred 
to several independent research groups starting their own 
clinical trials. Clinical studies involving larger subject bases 
are under way, and it is hoped that they will help clarify the 
roles o f lutein and zeaxanthin in the prevention and treatment 
o f AMD.
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